References

Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021

10.1016/s1473-3099(24)00007-0 · 2024 · External reference

Global Tuberculosis Report 2020 — reflections on the global TB burden, treatment and prevention efforts

10.1016/j.ijid.2021.02.107 · 2021 · External reference

Treatment and toxicity considerations in tuberculosis: a narrative review

2024 · External reference

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

10.1016/s0140-6736(19)30024-8 · 2019 · External reference

The social determinants of tuberculosis: from evidence to action

10.2105/ajph.2010.199505 · 2011 · External reference

Drug-resistant tuberculosis: a persistent global health concern

10.1038/s41579-024-01025-1 · 2024 · External reference

Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors

10.1371/journal.pone.0119332 · 2015 · External reference

Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China

10.1186/s12889-015-2327-8 · 2015 · External reference

Prevalence of long-term physical sequelae among patients treated with multi-drug and extensively drug-resistant tuberculosis: a systematic review and meta-analysis

10.1016/j.eclinm.2023.101900 · 2023 · External reference

A deadly equation: the global toll of US TB funding cuts

10.1371/journal.pgph.0004899 · 2025 · External reference

The fate of tuberculosis programmes without USAID

10.1016/j.lanmic.2025.101145 · 2025 · External reference

Impact of US funding cuts and stop work orders on TB services and research in South Africa

10.5588/ijtldopen.25.0168 · 2025 · External reference

Threat of HIV and tuberculosis drug resistance after US funding cuts

10.1016/s1473-3099(25)00209-9 · 2025 · External reference

Impact of US Government funding cessation on TB care and prevention: a multicountry survey in Africa

10.5588/ijtld.24.0215 · 2025 · External reference

Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis

10.1371/journal.pone.0270003 · 2022 · External reference

Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019

10.1016/s1473-3099(21)00449-7 · 2022 · External reference

Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study

10.1016/s1473-3099(18)30625-x · 2018 · External reference

The global burden of tuberculosis: results from the Global Burden of Disease Study 2015

10.1016/s1473-3099(17)30703-x · 2018 · External reference

Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement

10.1016/s0140-6736(16)30388-9 · 2016 · External reference

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

10.1016/s0140-6736(25)01917-8 · 2025 · External reference

Modeling causes of death: an integrated approach using CODEm

10.1186/1478-7954-10-1 · 2012 · External reference

Public health utility of cause of death data: applying empirical algorithms to improve data quality

10.1186/s12911-021-01501-1 · 2021 · External reference

Accounting for misclassified and unknown cause of death data in vital registration systems for estimating trends in HIV mortality

2021 · External reference

Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis

10.1371/journal.pone.0082235 · 2014 · External reference

Unresolved reference

2015 · External reference

Trimmed constrained mixed effects models: formulations and algorithms

10.1080/10618600.2020.1868303 · 2021 · External reference

Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

10.1016/s2214-109x(22)00429-6 · 2022 · External reference

Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review

10.1371/journal.pone.0017601 · 2011 · External reference

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

10.1016/s0140-6736(24)00933-4 · 2024 · External reference

Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020

10.1016/s0140-6736(22)00847-9 · 2022 · External reference

Health effects associated with smoking: a burden of proof study

10.1038/s41591-022-01978-x · 2022 · External reference

GBD 2010: design, definitions, and metrics

10.1016/s0140-6736(12)61899-6 · 2012 · External reference

Global, regional, and national burden of HIV/AIDS, 1990–2023, with burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023

2025 · External reference

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

10.1016/s1473-3099(10)70078-5 · 2010 · External reference

ART and prevention of HIV-associated tuberculosis

10.1016/s2352-3018(15)00081-8 · 2015 · External reference

Revisiting aid dependency for HIV programs in Sub-Saharan Africa

10.1016/j.puhe.2019.02.016 · 2019 · External reference

Tracking development assistance for health, 1990–2030: historical trends, recent cuts, and outlook

10.1016/s0140-6736(25)01240-1 · 2025 · External reference

Early impacts of the PEPFAR stop-work order: a rapid assessment

10.1002/jia2.26423 · 2025 · External reference

Unresolved reference

External reference

The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study

10.1016/s2214-109x(25)00232-3 · 2025 · External reference

A deadly equation: the global toll of US TB funding cuts

10.1371/journal.pgph.0004899 · 2025 · External reference

Impact of an international HIV funding crisis on HIV infections and mortality in low-income and middle-income countries: a modelling study

10.1016/s2352-3018(25)00074-8 · 2025 · External reference

Tuberculosis trends in eastern Europe and the former USSR

10.1016/0962-8479(94)90113-9 · 1994 · External reference

Twenty years of global surveillance of antituberculosis-drug resistance

10.1056/nejmsr1512438 · 2016 · External reference

Tuberculosis

10.1016/s0140-6736(24)02479-6 · 2025 · External reference

Management of drug-resistant tuberculosis

10.1016/s0140-6736(19)31882-3 · 2019 · External reference

Tuberculosis and HIV co-infection

10.1371/journal.ppat.1002464 · 2012 · External reference

Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis

10.1186/s12879-019-4317-4 · 2019 · External reference

HIV infection and multidrug-resistant tuberculosis: the perfect storm

10.1086/518665 · 2007 · External reference

Updates on the treatment of drug-susceptible and drug-resistant tuberculosis: an official ATS/CDC/ERS/IDSA clinical practice guideline

10.1164/rccm.202410-2096st · 2025 · External reference

Bedaquiline resistance: its emergence, mechanism, and prevention

10.1093/cid/cix992 · 2018 · External reference

Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study

10.1016/s1473-3099(21)00470-9 · 2022 · External reference

Acquired resistance of Mycobacterium tuberculosis to bedaquiline

10.1371/journal.pone.0102135 · 2014 · External reference

Recent advancements in tuberculosis (TB) treatment regimens

10.4103/jfmpc.jfmpc_1237_24 · 2025 · External reference

Potential trade-offs of proposed cuts to the US National Institutes of Health

10.1001/jamahealthforum.2025.2228 · 2025 · External reference

Unresolved reference

External reference

10.1016/s0140-6736(25)01637-x

10.1016/s0140-6736(25)01637-x · 2025 · External reference

Increasing tuberculosis burden in Latin America: an alarming trend for global control efforts

10.1136/bmjgh-2021-005639 · 2021 · External reference

Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected effects of policy alternatives: a mathematical modelling study

10.1016/s2468-2667(24)00192-0 · 2024 · External reference

“The end TB strategy” pathway in South America: out of track for 2025 milestones and 2035 eradication

2025 · External reference

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

10.1016/s0140-6736(23)01301-6 · 2023 · External reference

Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol

10.1016/s0140-6736(09)60744-3 · 2009 · External reference

Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies

10.1080/14622200210141000 · 2002 · External reference